Please use this identifier to cite or link to this item: http://cmuir.cmu.ac.th/jspui/handle/6653943832/66054
Full metadata record
DC FieldValueLanguage
dc.contributor.authorWorawat Poltabtimen_US
dc.contributor.authorKiadtisak Saenboonruangen_US
dc.date.accessioned2019-08-21T09:18:20Z-
dc.date.available2019-08-21T09:18:20Z-
dc.date.issued2019en_US
dc.identifier.citationChiang Mai Journal of Science 46, 4 (July 2019), 778 - 786en_US
dc.identifier.issn0125-2526en_US
dc.identifier.urihttp://it.science.cmu.ac.th/ejournal/dl.php?journal_id=10228en_US
dc.identifier.urihttp://cmuir.cmu.ac.th/jspui/handle/6653943832/66054-
dc.description.abstractThis work assessed the activity concentrations of 226Ra, 232Th, 40K, and 137Cs, their corresponding annual effective doses, and their radiological health risks associated with the consumption of infant formulas in Thailand. The results showed that the average (± standard deviation) activity concentrations of 226Ra, 232Th, 40K, and 137Cs radionuclides were 3.20±0.51 Bq kg-1, 1.24±0.10 Bq kg-1, 213.20±25.50 Bq kg-1, and 4.90±0.74 Bq kg-1, respectively, leading to an average annual effective dose for infants aged ≤1 year and 1­­­–2 years of 762.82±91.34 µSv year-1 and 189.60±22.47 µSv year-1, respectively, and radiological health risks of (5.63±0.66)×10-6 and (3.77±0.44)×10-6, respectively. The overall results suggested that infant formulas in Thailand posed no significant effective dose and radiological health risks, implying safe consumption for infants.en_US
dc.language.isoEngen_US
dc.publisherScience Faculty of Chiang Mai Universityen_US
dc.subjectpowdered milken_US
dc.subjectradioactivityen_US
dc.subjectannual effective doseen_US
dc.subjectrisken_US
dc.subjectgamma spectroscopyen_US
dc.titleAssessment of Activity Concentrations and Their Associated Radiological Health Risks in Commercial Infant Formulas in Thailanden_US
Appears in Collections:CMUL: Journal Articles

Files in This Item:
There are no files associated with this item.


Items in CMUIR are protected by copyright, with all rights reserved, unless otherwise indicated.